Literature DB >> 10950041

Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study.

J B Felder1, B I Korelitz, R Rajapakse, S Schwarz, A P Horatagis, G Gleim.   

Abstract

OBJECTIVE: The aim of this study was to determine whether a relationship exists between the use of nonsteroidal antiinflammatory drugs (NSAIDs) and exacerbation or onset of inflammatory bowel disease (IBD).
METHODS: Sixty consecutive IBD patients admitted to the hospital were carefully interviewed to ascertain whether they used NSAIDs and the relationship in time and duration to the exacerbation (or onset) of the IBD; 62 patients with irritable bowel syndrome were similarly interviewed and served as controls.
RESULTS: In 31% of our IBD population there was a correlation between use of NSAIDs and IBD activity, whereas in only 2% of the irritable bowel syndrome population who used NSAIDs did this relationship exist.
CONCLUSIONS: NSAIDs provoke disease activity in both ulcerative colitis and Crohn's disease and should be avoided in patients with a history of IBD whenever possible.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950041     DOI: 10.1111/j.1572-0241.2000.02262.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  69 in total

Review 1.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 2.  Standards of medical treatment and nutrition in Crohn's disease.

Authors:  Britta Siegmund; Martin Zeitz
Journal:  Langenbecks Arch Surg       Date:  2004-09-23       Impact factor: 3.445

3.  Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease.

Authors:  Millie D Long; Michael D Kappelman; Christopher F Martin; Wenli Chen; Kristen Anton; Robert S Sandler
Journal:  J Clin Gastroenterol       Date:  2016-02       Impact factor: 3.062

Review 4.  The epidemiology and risk factors of inflammatory bowel disease.

Authors:  Yulan Ye; Zhi Pang; Weichang Chen; Songwen Ju; Chunli Zhou
Journal:  Int J Clin Exp Med       Date:  2015-12-15

5.  Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: a case control study in Iran.

Authors:  Farzad Firouzi; Ali Bahari; Rahim Aghazadeh; Mohammad Reza Zali
Journal:  Int J Colorectal Dis       Date:  2005-06-04       Impact factor: 2.571

Review 6.  Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?

Authors:  Mario Guslandi
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 7.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

8.  Seasonal variations in the onset of ulcerative colitis in Japan.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Hiroaki Saito; Tetsuji Yokoyama; Tomoyoshi Shibuya; Naoto Sakamoto; Kan Uchiyama; Hiroshi Arakawa; Taro Osada; Akihito Nagahara; Sumio Watanabe; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 9.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

10.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.